1.62

8.99% -0.16

After Hours: 1.60 -0.02 -1.23%

Neuronetics Inc (STIM)

Overview News Price History Option Chain Financials Discussions Forecast

Neuronetics Inc stock is traded at $1.62, with a volume of 3.15M. It is down -8.99% in the last 24 hours and up +33.88% over the past month. Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Previous Close:

$1.78

Open:

$1.74

24h Volume:

3.15M

Relative Volume:

1.46

Market Cap:

$112.73M

Revenue:

$151.64M

Net Income/Loss:

$-37.23M

P/E Ratio:

-2.9649

EPS:

-0.5464

Net Cash Flow:

$-13.58M

1W Performance:

-7.95%

1M Performance:

+33.88%

6M Performance:

-14.74%

1Y Performance:

-57.70%

1-Day Range:

$1.56

$1.88

1-Week Range:

$1.56

$2.33

52-Week Range:

$0.80

$4.8495

Neuronetics Inc Stock (STIM) Company Profile

Name

Neuronetics Inc

Sector

Healthcare (1092)

Industry

Medical Devices (141)

Phone

877-600-7555

Address

3222 PHOENIXVILLE PIKE, MALVERN, PA

Employee

658

Twitter

@tmstherapy

Next Earnings Date

2026-08-04

Latest SEC Filings

STIM's Discussions on Twitter

Compare STIM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STIM Neuronetics Inc	1.62	123.87M	151.64M	-37.23M	-13.58M	-0.5464
ABT Abbott Laboratories	100.68	172.14B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	319.87	126.97B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.20	106.96B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	44.03	66.32B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.73	50.58B	6.30B	1.07B	1.09B	1.8406

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jul-24-18	Initiated	Canaccord Genuity	Buy

View All

Neuronetics Inc Stock (STIM) Latest News

10:12 AM

Neuronetics Could Double, But The Balance Sheet May Crack First (NASDAQ:STIM) - Seeking Alpha

10:12 AM

Jul 16, 2026

Q3 2025 Neuronetics Inc Earnings Call Transcript - GuruFocus

Jul 16, 2026

Jul 15, 2026

What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout | AI

Jul 15, 2026

Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit - Yahoo Finance

Jul 14, 2026

Jul 13, 2026

Neuronetics (STIM) EVP Cory Anderson reports PRSU awards tied to cash metrics - Stock Titan

Jul 13, 2026

Jul 07, 2026

Neuronetics to Participate in a Panel Discussion at B. Riley Securities Mind, Muscle and Vision Summit on July 16, 2026 - marketscreener.com

Jul 07, 2026

Jul 06, 2026

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 - The Manila Times

Jul 06, 2026

Neuronetics to Participate at B. Riley Securities’ Mind, Muscle & Vision Summit - Quiver Quantitative

Jul 06, 2026

Neuronetics joins neuropsychiatry panel at B. Riley investor summit - Stock Titan

Jul 06, 2026

Neuronetics to join B. Riley panel on neuropsyc... - Pluang

Jul 06, 2026

Jul 03, 2026

Neuronetics stock leans on its core therapy platform. - Ad Hoc News

Jul 03, 2026

Jul 02, 2026

STIM News | NEURONETICS INC (NASDAQ:STIM) - ChartMill

Jul 02, 2026

Jun 30, 2026

STIM Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market ResponseBook Value Growth - dars.gov.et

Jun 30, 2026

Jun 29, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Dynamic Index - marketscreener.com

Jun 29, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000E Index - marketscreener.com

Jun 29, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2500 Index - marketscreener.com

Jun 29, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Index - marketscreener.com

Jun 29, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Neuronetics, Inc. Actuals & Estimates (NASDAQ:STIM) - TradingView

Jun 26, 2026